immunity News and Research

RSS

UC Davis joins with Pfizer for COVID-19 booster vaccine trial

As COVID-19 booster shots begin for those with compromised immune systems, researchers at the UC Davis School of Medicine continue to collect data from clinical trial participants.

13 Aug 2021

L452R mutations may have triggered the emergence of several COVID-19 variants

Most of the recently risen coronavirus variants of interest or concern -- delta, kappa, epsilon, iota and lambda -- are universally carrying a mutation in amino acid L452 of the Spike protein that helps the virus bind to host cells.

13 Aug 2021

Study: 90% of children with ADHD continue to experience residual symptoms into young adulthood

Most children diagnosed with attention deficit hyperactive disorder (ADHD) don't outgrow the disorder, as widely thought.

13 Aug 2021

CDC recommends additional dose of mRNA COVID-19 vaccine in moderately to severely immunocompromised people

Today, I signed CDC's Advisory Committee on Immunization Practices' (ACIP) recommendation that endorsed the use of an additional dose of COVID-19 vaccine for people with moderately to severely compromised immune systems after an initial two-dose vaccine series.

13 Aug 2021

Pfizer CEO to public: Just trust us on the covid booster

Pfizer CEO Albert Bourla was confident in June about the ability of his company's vaccine to protect against the highly contagious delta variant, as it marched across the globe and filled U.S. hospitals with patients.

13 Aug 2021

How replication and recombination contribute to emergence of SARS-CoV-2 variants

The coronavirus disease 2019 (COVID-19) pandemic has been caused by the rapid outbreak of a novel coronavirus, namely, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 was first reported in late December 2019 in Wuhan, China. Since then, the virus has already claimed more than 4.3 million lives worldwide.

13 Aug 2021

Research debunks myth that COVID vaccination promotes mutations

A study conducted by researchers at the University of Maryland, USA, has highlighted the importance of coronavirus disease 2019 (COVID-19) vaccination in reducing the frequency of mutations in the delta variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

13 Aug 2021

Study finds four circulating miRNAs which could effectively inhibit SARS-CoV-2 replication

In a new study, Chen-Yu Zhang's group from Nanjing University presents a rather striking finding that four circulating miRNAs, which are high in healthy people and much lower in older people and diabetic patients, could effectively inhibit SARS-CoV-2 replication by directly targeting the S protein.

12 Aug 2021

Nanotechnology may help improve treatment for colorectal cancer and melanoma

University of Arizona Health Sciences researchers recently completed a study that has the potential to improve cancer treatment for colorectal cancer and melanoma by using nanotechnology to deliver chemotherapy in a way that makes it more effective against aggressive tumors.

12 Aug 2021

UC San Diego scientists develop new method to keep cultured cells healthy

Hematopoietic stem cells — the precursors to blood cells — have been notoriously difficult to grow in a dish, a critical tool in basic research.

12 Aug 2021

Ten-fold reduced risk of workplace SARS-CoV-2 infection in seropositive essential workers

A reassuring new study supports the opening of workplaces to seropositive workers in view of the extremely low risk of reinfection observed in this cohort.

11 Aug 2021

COVID-19 risks likely to shift from older adults to younger children

Within the next few years, as the SARS-CoV-2 virus becomes endemic in the global population, COVID-19 may behave like other common-cold coronaviruses, affecting mostly young children who have not yet been vaccinated or exposed to the virus, according to new modeling results.

11 Aug 2021

Two-arm molecule can deplete cancer-protecting cells to promote immune responses against tumors

A two-arm molecule can effectively deplete cancer-protecting cells inside tumors, allowing the immune system to fight off tumors without becoming overactive. The finding, published online in Science Translational Medicine, could lead to new types of cancer immunotherapies.

11 Aug 2021

Evaluation of mRNA vaccine responses with a surrogate SARS-CoV-2 viral neutralization assay

In the current study, the authors evaluate several different competitive ELISAs that could be used to measure serum antibodies.

11 Aug 2021

COVID-19 vaccine likely protects people living with HIV, study shows

A Johns Hopkins Medicine research team has shown that people living with the human immunodeficiency virus (HIV) are likely to be protected against SARS-CoV-2, the virus that causes COVID-19, if they are fully vaccinated.

11 Aug 2021

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

One dose of a new monoclonal antibody discovered and developed at the National Institutes of Health safely prevented malaria for up to nine months in people who were exposed to the malaria parasite.

11 Aug 2021

COVID-19 booster shot in autumn will effectively protect against existing and future variants

Scientists at the University of Nottingham have confirmed that an autumn 'booster' dose of a Covid-19 vaccine will be an effective way to protect people from existing, and potentially future, variants of concern.

11 Aug 2021

COVID-19 vaccines offer better protection than natural immunity alone

Now, the U.S. Centers for Disease Control and Prevention (CDC) reports that among people who were previously infected with SARS-CoV-2, those who were still unvaccinated are more likely to be reinfected than those fully vaccinated after prior infection.

11 Aug 2021

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

A new study demonstrates that the two mRNA vaccines have widely varying efficacies against the SARS-CoV-2 Delta variant.

10 Aug 2021

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

A new study explores the polyclonal antibody response to SARS-CoV-2 in greater detail.

10 Aug 2021

immunity News and Research

UC Davis joins with Pfizer for COVID-19 booster vaccine trial

L452R mutations may have triggered the emergence of several COVID-19 variants

Study: 90% of children with ADHD continue to experience residual symptoms into young adulthood

CDC recommends additional dose of mRNA COVID-19 vaccine in moderately to severely immunocompromised people

Pfizer CEO to public: Just trust us on the covid booster

How replication and recombination contribute to emergence of SARS-CoV-2 variants

Research debunks myth that COVID vaccination promotes mutations

Study finds four circulating miRNAs which could effectively inhibit SARS-CoV-2 replication

Nanotechnology may help improve treatment for colorectal cancer and melanoma

UC San Diego scientists develop new method to keep cultured cells healthy

Ten-fold reduced risk of workplace SARS-CoV-2 infection in seropositive essential workers

COVID-19 risks likely to shift from older adults to younger children

Two-arm molecule can deplete cancer-protecting cells to promote immune responses against tumors

Evaluation of mRNA vaccine responses with a surrogate SARS-CoV-2 viral neutralization assay

COVID-19 vaccine likely protects people living with HIV, study shows

Small NIH clinical trial shows that new monoclonal antibody can prevent malaria

COVID-19 booster shot in autumn will effectively protect against existing and future variants

COVID-19 vaccines offer better protection than natural immunity alone

Both mRNA vaccines protect against symptomatic disease with SARS-CoV-2 Delta variant

Study defines SARS-CoV-2 antibodies associated with neutralization and effector functions

Exploring Strategies for Targeting Kinases in Innate Immunity eBook

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News